Importantly, KSQ‐4279 combination here was shown to significantly sensitize the resistant tumor specimens to doxorubicin treatment, and a more significant enhancement in the antitumor effect was observed in the specimens with higher ABCB1 expression (Figure 2K–M). The gene discussed is ABCB1; the disease is neoplasm.